Macquarie Group LTD Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Macquarie Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $57.4 Million - $101 Million	-690,008 Reduced 91.65%	62,875 $9.16 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $1.62 Million - $2.1 Million	14,684 Added 1.99%	752,883 $89.3 Million
Q4 2021 Feb 11, 2022	BUY	$99.73 - $148.48 $21.7 Million - $32.4 Million	218,075 Added 41.93%	738,199 $102 Million
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $51.2 Million - $72 Million	518,251 Added 27669.57%	520,124 $72.3 Million
Q2 2021 Aug 13, 2021	SELL	$65.78 - $105.02 $4,736 - $7,561	-72 Reduced 3.7%	1,873 $182,000
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $29,023 - $41,562	-453 Reduced 18.89%	1,945 $133,000
Q2 2020 Aug 11, 2020	BUY	$29.01 - $74.23 $37,654 - $96,350	1,298 Added 118.0%	2,398 $175,000
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $44,946 - $63,415	1,100 New	1,100 $60,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.